These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Quick, easy, and safe? On the use of low-molecular-weight heparins in cardioversion of atrial fibrillation. Stellbrink C Eur Heart J; 2006 Dec; 27(23):2742-3. PubMed ID: 17098755 [No Abstract] [Full Text] [Related]
6. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes]. MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309 [No Abstract] [Full Text] [Related]
7. The status of new anticoagulants. Bates SM; Weitz JI Br J Haematol; 2006 Jul; 134(1):3-19. PubMed ID: 16803562 [TBL] [Abstract][Full Text] [Related]
8. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes. Haas S Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477 [TBL] [Abstract][Full Text] [Related]
9. [Assessment of anticoagulant therapy in primary nephrotic syndrome]. Duan S; Luo J; Liu F Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):301-3. PubMed ID: 12016815 [No Abstract] [Full Text] [Related]